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Abstract 
Uveal melanoma is the most common primary ocular neoplasm in adults. It is peculiar for its hematogenous 
dissemination and its high propensity to spread to the liver. Current treatments rarely prolong patient survival. We 
hypothesized that metastatic uveal melanoma cells modulate the function of surrounding hepatic stellate cells to 
facilitate their own growth and survival. This study was conducted to investigate the role of the hepatic 
microenvironment on uveal melanoma aggressiveness. We demonstrated that the paracrine signaling of 
surrounding hepatic stellate cells have more transcriptional impact on metastatic uveal melanoma cells. 
Upregulated transcripts were linked to inflammation and included several interleukins. The uveal melanoma-
stellate cell crosstalk induced as well the expression of transmembrane integrins. In addition, the interleukin-6 
receptor inhibitor Tocilizumab did not reduce the growth of uveal melanoma cells. Our results provide evidence 
that inflammatory mediators are key players in the homing of uveal melanoma cells to the liver. The bidirectional 
crosstalk between uveal melanoma cells and hepatic stellate cells involved pro-fibrogenic interleukins. The 
inflammatory characteristics of the metastatic microenvironment might offer relevant therapeutic opportunities in 
uveal melanoma. 
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1. Introduction 
Uveal melanoma (UM) is the most common primary eye tumor in adults, with an estimated annual frequency 
of 5 to 10 cases per million people in developed countries (Singh et al., 2005). UM is peculiar for its 
hematogenous dissemination and its high propensity to spread to the liver (Landreville et al., 2008). Current 
treatments rarely prolong patient survival: the metastasis-related mortality is 20-30% at 5 years and 45% at 15 
years (Singh et al., 2011). 
The liver is one of the most targeted organs by gastrointestinal and UM metastases, yet the reasons of this 
tropism remain elusive. Previous studies pointed out to an important role of growth factors mainly synthesized in 
the liver (HGF/IGF-1) and the expression of corresponding receptors on metastatic UM cells (UMCs; c-
MET/IGF-1R) in UM spreading (Barisione et al., 2015; Economou et al., 2008). The microenvironment of the 
metastasis is an integral part of its physiology and cancer cells need among others surrounding stromal cells for 
their growth and survival (Mbeunkui and Johann, 2009). Hepatic stellate cells (HSCs) are the most reactive 
stromal cells of the liver in presence of invading cancer cells (Vidal-Vanaclocha, 2008). Indeed, while they are 
quiescent cells storing retinoids in healthy liver, they switch into extracellular matrix–producing myofibroblasts 
when micrometastases develop in the sinusoidal area of lobules (Vidal-Vanaclocha, 2008). Their activation 
triggers a desmoplastic stromal response that exhibits a pro-invasive effect on colorectal and pancreatic cancer 
cells, stiffens the extracellular matrix, and suppresses the immune cell infiltration (Yin et al., 2013; Yu et al., 
2004). Interestingly, Coupland and collaborators identified that “hepatic fibrosis” and “HSC activation” were 
among the top-featured pathways found in the UM secretome (Angi et al., 2016). HSCs were previously observed 
surrounding UM metastases (Grossniklaus, 2013; Lattier et al., 2013), and their conditioned medium increased the 
migration and invasion of UMCs, as well as their resistance to the MEK inhibitor trametinib (Cheng et al., 2017). 
In addition, an association between altered inflammatory microenvironment and liver fibrosis was previously 
suggested (Grossniklaus et al., 2016; Krishna et al., 2017). Grossniklaus and collaborators proposed that the 
infiltrative growth pattern of UM metastasis, in which malignant lesions are encapsulated by fibrous collagens, 
was restrained by modifications of the immune microenvironment within the sinusoidal space (Grossniklaus et al., 
2016). Coupland and collaborators demonstrated a spatial distribution of CD8-positive tumor infiltrating 
lymphocytes in metastatic UM, which were predominantly found at the tumor/normal parenchyma interface 
(Krishna et al., 2017). Activated HSCs and their fibrosis need therefore to be considered as a therapeutic target in 
the context of combinatorial drug regimens. 
The purpose of this study was to investigate the intrinsic differences between primary and metastatic UMCs in 
their interactions with HSCs. We found that the co-culture of metastatic UMCs with activated HSCs resulted in a 
bidirectional crosstalk associated with prominent transcriptional changes, and an increase in secretion of 
inflammatory mediators. 
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2. Materials and methods 
2.1 Cell lines and co-culture experiments  
The human LX-2 cell line was kindly provided by Dr. Scott L. Friedman (Mount Sinai School of Medicine, 
New York, NY) and was maintained as previously described (Xu et al., 2005). The Mel270 cell line was derived 
from a human primary UM (kindly provided by Dr. Martine Jager, University of Leiden, The Netherlands) 
(Verbik et al., 1997). The OMM2.3 metastatic cell line was established from a biopsy of a liver nodule from the 
same patient (Verbik et al., 1997). Both cell lines were grown as previously described (Babchia et al., 2008), and 
were authenticated using DNA sequencing for GNAQ and GNA11 mutations (positive for GNAQ Q209P) and 
short tandem repeat genotyping (Authentifiler PCR Amplification Kit; Life Technologies) as previously described 
(Calipel et al., 2011; Mouriaux et al., 2016b). All cell lines were tested routinely for mycoplasma infection by 
PCR (ATCC). Co-cultures were conducted in serum-free and antibiotic-free DMEM (Invitrogen) using 6-well 
plates and 1 µm pore-size Transwell inserts (BD Biosciences), which allow the diffusion of soluble factors but 
prevent cell migration (Supplementary Fig. 1). All cell cultures were maintained at 37°C in a 5% CO2 atmosphere. 
Both cell types were then cultured alone or side-by-side for 48 hours (with or without the IL6 receptor inhibitor 
Tocilizumab (TCZ) at 600 ng/mL diluted directly in serum-free medium). RNA and proteins were then extracted 
from the cells into the 6-well plates for analysis. Supernatants were collected from inserts for ELISA or used as 
conditioned medium (CM) for further treatments. 
 
2.2 Microarray analysis 
Total RNA was purified from cells at 80% confluence (n=3) with the RNeasy kit (Qiagen). Genome-wide 
expression profiling was conducted using the low-input Quick Amp Labeling Kit and human SurePrint G3 
Human Gene Expression v2 8x60K Microarray Kits (Agilent Technologies). Starting from 150 ng of total RNA, 
the amplification yield was 7.4 ± 0.94 µg of cRNA and the specific activity was 18.43 ± 3.91 pmol of Cy3 per µg 
of cRNA. Gene expression data were processed using the Feature Extraction and GeneSpring softwares (Agilent 
Technologies) and further analyzed using the R-based BRB-Array Tools. Briefly, differentially expressed 
transcripts were identified by a two-sample univariate t-test and a random variance model (P<0.01) (Coulouarn et 
al., 2012). Permutation P values for significant transcripts were computed on the basis of 10,000 random 
permutations.  
 
2.3 Real-Time reverse transcriptase PCR 
The expression of relevant transcripts was measured by quantitative real-time PCR (QPCR) using total RNA 
isolated for the microarray analysis (Coulouarn et al., 2009). Melting analysis was conducted to validate the 
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specificity of PCR products. Quantitative analysis of PCR data was performed with the 2-∆∆Ct method using beta-
Actin (ACTB) and TATA-binding protein (TBP) Ct values for normalization. 
 
2.4 Quantification of cytokines by ELISA 
UMC lines were grown as described in Supplementary Fig. 1. Supernatants were collected after 48 hours. The 
amount of cytokines IL1β, IL6, IL6ST, IL8 and VEGFA secreted in the medium was determined by ELISA using 
100 µl of supernatant. The following kit were used: Human IL1β ELISA Kit (Sigma-Aldrich), Human IL6 
PicoKine ELISA Kit (Boster Biological Technology), Human sGP130/IL6-ST PicoKine ELISA Kit (Boster 
Biological Technology), Human IL8/CXCL8 ELISA Kit (Sigma-Aldrich), and Human VEGF DuoSet ELISA 
(R&D Systems) according to the manufacturer’s protocol. The absorbance at 450 nm of the colored solution was 
quantified with a spectrophotometer (Multiskan Ascent, Thermo), normalized for the number of cells and reported 
as pg/mL.  
 
2.5 Cell adhesion assay 
UMCs and HSCs were resuspended in conditioned medium at 100,000 cells/well, and 150 µL were seeded into 
a plate precoated with various extracellular matrix proteins (Cell Biolabs; Supplementary Fig. 2). After 90 min, 
the wells were washed with serum-free DMEM, and 150 µL from each extracted sample was transferred to a 96-
well microtiter plate. The absorbance at 560 nm of the colored solution was quantified with a spectrophotometer 
(Multiskan Ascent, Thermo).  
 
2.6 Cell proliferation 
Mel270 and OMM2.3 cell lines were seeded in triplicate in 96-well plates at a density of 10,000 cells/well. 
Following a 24 hours incubation at 37°C, the medium was replaced by serum-free medium supplemented with 
50% (v/v) conditioned medium derived from monocultures or co-cultures of Mel270/LX-2 and OMM2.3/LX-2. 
UMC and LX-2 cells were seeded in triplicate in 24-well plates at 80% of confluence alone or in co-culture, with 
or without TCZ. The number of viable cells was determined by using the MTT (3-(4,5- dimethyl thiazol-2-yl)-
2,5-diphenyl tetrazolium bromide) colorimetric method after 48 hours of culture. The absorbance at 560 nm was 
quantified on a spectrophotometer (Multiskan Ascent, Thermo). 
 
2.7 Western blotting 
Cells were lysed, resolved, electroblotted (Babchia et al., 2008), and probed with polyclonal antibodies 
directed against Cyclin D1 (dilution 1:1,000; Cell Signaling Technology), p21 (dilution 1:1,000; Cell Signaling 
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Technology), STAT3 (dilution 1:1,000; Cell Signaling Technology), and phospho-STAT3 (Tyr705) (dilution 
1:1,000; Cell Signaling Technology) to analyze the activation of these kinases in co-culture conditions. 
Membranes were probed with a rabbit monoclonal antibody directed against the β-Actin (dilution 1:1,000; Santa 
Cruz Biotechnology) as control for equal loading. Primary antibodies were tagged with specific secondary 
horseradish peroxidase-conjugated antibodies. Antibody complexes were detected by enhanced 
chemiluminescence (ECL; Amersham). The intensity of the luminescence was quantified using a charge-coupled 
device camera combined with an image analysis system (CHEMI-SMART 5000, POMPER150 W; Bioblock 
Scientific, Fisher). 
 
2.8 Statistical analysis 
The two-tailed Student’s t-test (normal distribution with equal variance) and the Mann-Whitney U test 
(nonparametric) were used for statistical analysis. A value of P<0.05 was considered to be statistically significant. 
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3. Results 
3.1 Bidirectional crosstalk between UMCs and activated HSCs 
We started our study by comparing the morphology and transcriptomic differences between the primary tumor 
(Mel270; non-metastatic) and metastatic (OMM2.3) UMCs (Supplementary Fig. 3). Our analysis of the 
transcriptome reveals 256 probes (corresponding to 216 non-redundant well-annotated mRNAs) differentially 
expressed between Mel270 and OMM2.3 cells (Supplementary Fig. 3B; P<0.01, fold change>1.5). Several 
transcripts were upregulated in OMM2.3 cells like those associated to extracellular matrix (e.g. MATN4, 
COL9A1), signaling pathways WNT and BRAF, liver-specific genes (e.g. HNF1A, APOC2), and inflammation 
(e.g. NFKB, TNFSF10, TNFRSF21, TNFAIP2). We also identified downregulated transcripts in OMM2.3 cells 
such as CCL20 and CCL3L3. In addition, we observed an elevated secretion of the cytokines IL6ST, IL8 and 
VEGFA in both cell lines, with higher levels in Mel270 (Supplementary Table 1). Both cytokines IL1β and IL6 
were expressed at low levels in UMC lines (Supplementary Fig. 3C). These results demonstrate that there are 
transcriptomic and secretomic differences between both UMC lines according to their original microenvironment 
even if they are derived from the same patient. Next, we hypothesized that the exposure of UMC lines to soluble 
factors produced by activated HSCs may change their phenotype and gene expression profile. Mel270 and 
OMM2.3 cells were thus co-cultured with LX-2 cells (Supplementary Fig. 1) as a paradigm to study the crosstalk 
between non-metastatic or metastatic UMCs and activated HSCs. No morphological changes were observed in 
UMC lines in co-culture conditions (Supplementary Fig. 3A). The analysis of gene expression profiles by means 
of class comparison allowed identifying 1,200 and 312 transcripts whose expression was modulated significantly 
in LX-2 cells when co-cultured with metastatic or non-metastatic UMCs, respectively (Fig. 1A). A similar 
comparison determined that 1,627 and 501 transcripts were significantly modulated by LX-2 cells in metastatic 
and non-metastatic UMCs, respectively (Fig. 1B). Over 349 transcripts were upregulated and 152 were 
downregulated in non-metastatic UMCs when co-cultured with LX-2 cells, while 1,013 upregulated transcripts 
and 614 downregulated transcripts were identified in metastatic UMCs (Supplementary Fig. 4A,C, Supplementary 
Tables 2-3). Over 747 transcripts were upregulated and 453 were downregulated in LX-2 cells when co-cultured 
with metastatic UMCs, compared to 252 upregulated transcripts and 60 downregulated transcripts in presence of 
non-metastatic UMCs (Supplementary Fig. 4B,D, Supplementary Tables 4-5). These results suggest that 
metastatic UMCs are more responsive to HSCs than non-metastatic UMCs, and conversely. In addition, volcano 
plots highlighting the significant differences in expressed transcripts in co-culture conditions showed that 
exposition to LX-2 cells activated three times more transcripts in metastatic UMCs compared to non-metastatic 
cells (Fig. 1C; P<0.001, fold change>2). Furthermore, metastatic UMCs upregulated fourteen times more 
transcripts in LX-2 cells than non-metastatic cells (Fig. 1D; P<0.001, fold change>2). According to these 
microarray results, the number of overexpressed transcripts is twice the number of repressed transcripts, and it 
thus reveals a bidirectional crosstalk between UMCs and HSCs.  
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3.2 UMC-HSC crosstalk promotes inflammation 
Data mining of genes differentially expressed between monoculture and co-culture conditions demonstrated 
that inflammation-related genes ranked first (e.g. NFKB pathway), followed by growth factors, signaling 
pathways such as Notch, and extracellular matrix genes (e.g. collagens, matrix metallopeptidases, integrin 
receptors). Upregulation of many inflammatory cytokines like IL6, IL6ST and CXCL8 (namely IL8) was 
observed in all co-culture conditions (Fig. 1C-D). These data indicate that co-culturing UMCs with activated 
HSCs generates a pro-inflammatory microenvironment. We then validated the microarray data by QPCR. There 
was a significant upregulation of cytokine transcripts IL1β (5.5-7.5 fold change, P<0.01), IL6 (2-10 fold change, 
P<0.05) and IL8 (3-164 fold change, P<0.01) in several co-culture conditions (Fig. 2). IL6ST was significantly 
increased only in the OMM2.3/LX-2 condition (4 fold change, P<0.001; Fig. 2B). Again, the response was more 
pronounced in metastatic UMC-HSC conditions (Fig. 2B,D). Moreover, we confirmed by ELISA the upregulation 
of corresponding secreted proteins IL6 in both UMC/LX-2 conditions (32-52 fold change, P<0.001; Fig. 3A-B), 
IL6ST in LX-2/UMC conditions (2.5-3 fold change, P<0.01; Fig. 3C-D), and IL8 in all co-culture conditions 
except in the LX-2/Mel270 condition (3-47 fold change, P<0.001; Fig. 3). IL1β was expressed at low levels and 
did not significantly increase in co-culture (Fig. 3). Collectively, these results demonstrate that co-culturing 
UMCs with activated HSCs induces pro-inflammatory signals. In addition, we observed a significant upregulation 
of the VEGFA transcript in all co-culture conditions (5-10.5 fold change, P<0.001; Fig. 2) and a significant 
increased of the secreted protein in LX-2/UMC conditions (5-9 fold change, P<0.001; Fig. 3), suggesting that the 
bidirectional crosstalk between UMCs and HSCs generates also a pro-angiogenic microenvironment.  
 
3.3 UMC-HSC crosstalk induces the expression of cell adhesion receptors 
Because integrins may play a role in tumor inflammation and growth through their interactions with the 
extracellular matrix, stromal cells and growth factors, we focused the analysis of our microarray data on integrin 
subunits (Supplementary Fig. 5A). ITGA5, ITGB2, ITGB3 and ITGB8 were increased in LX-2 cells in co-culture 
with UMCs (2-21 fold change; Supplementary Fig. 5B), while several were upregulated in metastatic UMCs co-
cultured with LX-2 cells (ITGA1, ITGA3, ITGA4, ITGAX, ITGB4; 2-4 fold change; Supplementary Fig. 5C) 
compared to non-metastatic cells (ITGB3; 2 fold change; Supplementary Fig. 5C). Only ITGA10 was decreased 
in both UMC lines in co-culture with LX-2 cells (Supplementary Fig. 5C). Therefore, we analyzed the effect of 
the bidirectional crosstalk on cell adhesion to extracellular matrix proteins such as fibronectin (FN), collagens I or 
IV (COL I, COL IV), laminin (LN) and fibrinogen (FBG). Interestingly, the Mel270/LX-2 conditioned medium 
increased the adhesion of Mel270 cells to all extracellular matrix components (>50%; Fig. 4A), while the 
adhesion of OMM2.3 cells was slightly increased only for FBG (17%; Fig. 4B) when they were incubated with 
the OMM2.3/LX-2 conditioned medium. The adhesion of LX-2 cells to COL IV and LN was slightly decreased 
(12 and 17%, respectively; Fig. 4C) when incubated in the LX-2/Mel270 conditioned medium. The LX-
2/OMM2.3 conditioned medium did not change their adhesion to any extracellular matrix proteins (Fig. 4D). 
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These results indicate that co-culturing UMCs with activated HSCs specifically increases the cell adhesion of 
non-metastatic cells to the extracellular matrix. 
 
3.4 UMC-HSC crosstalk has no effect on cell proliferation 
Treatments with the conditioned medium of co-culture conditions had no effect on the proliferation of both 
UMCs and HSCs as quantified by MTT assays (Fig. 5A). Next, we investigated the mRNA abundance of the 
proliferation marker MKI67 by QPCR (Fig. 5B). We observed no significant difference in its expression between 
monocultures and co-culture conditions for all cell lines. Therefore, we analyzed the impact of the bidirectional 
crosstalk on the levels of cell cycle markers Cyclin D1 (CCND1) and p21 (CDKN1A) by microarray and Western 
blotting (Fig. 5C,D). The CDKN1A transcript was increased more than two times only in the Mel270/LX2 
condition (P<0.001; Fig. 5C). Co-culture conditions decreased the protein expression of Cyclin D1 and p21 in 
UMC lines (Fig. 5D). The Cyclin D1 was barely expressed in LX-2 cells compared to p21 (Fig. 5D). These results 
indicate that the UMC-HSC crosstalk has no effect on cell proliferation. 
 
3.5 Tocilizumab (TCZ) reduces the inflammation caused by the UMC-HSC crosstalk 
Because IL6 was significantly increased in co-culture conditions, we decided to block the binding to its 
receptor by using TCZ. This humanized anti-human IL6 receptor (IL6R) monoclonal antibody inhibits the binding 
of both the soluble and membrane-bound forms of the IL6R, leading to the blockade of many biological functions 
of IL6 (Sato et al., 1993). A growing number of clinical studies have shown the potential use of TCZ to treat 
inflammatory and autoimmune diseases (Nishimoto et al., 2005). Therefore, we hypothesized that the exposure of 
UMC-HSC co-cultures to TCZ may reduce the inflammation-induced cytokine expression. We showed by QPCR 
that the TCZ decreases the expression of the IL6ST transcript in both UMC/LX-2 conditions (54-68%, P<0.001; 
Fig. 6A-B). Maximal inhibition by TCZ was observed with IL1β and to a greater extent in non-metastatic UMCs 
(59-85%, P<0.001; Fig. 6A-B). Minimal inhibition was seen with IL6 in both UMC lines suggesting the presence 
of an IL6 autocrine loop (17-40%, P<0.05; Fig. 6B-D). In addition, there was a decrease in the expression of IL8 
(31-57%, P<0.05) and VEGFA (43-54%, P<0.01) in both UMC/LX-2 conditions (Fig. 6A-B). Because the IL6 
binds to the IL6R inducing a homodimerization of the receptor and a subsequent activation of JAK/STAT, ERK 
and PI3K pathways (Johnson et al., 2012), we hypothesized that the IL6 regulates the inflammation in UMC-HSC 
co-cultures via the JAK/STAT pathway, and that TCZ should inhibit the activation of STAT3. Indeed, we 
demonstrated an increase in the phosphorylation of STAT3 in both UMC/LX-2 conditions (Supplementary 
Fig. 6A). A treatment with TCZ reduced the level of phospho-STAT3 (Supplementary Fig. 6A), suggesting that 
the IL6 controls the inflammation in UMCs via an activation of STAT3. However, a treatment with TCZ did not 
have a significant effect on cell proliferation (Supplementary Fig. 6B-D). There was a significant upregulation of 
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the STAT3 transcript in the OMM2.3/LX2 condition (Supplementary Fig. 6E-F). STAT3 levels were decreased 
post-TCZ treatment in all co-culture conditions (27-54%, P<0.05; Supplementary Fig. 6G-H).  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 11
4. Discussion 
HSCs are characterized by their expression of key receptors regulating fibrosis such as PDGFRβ, Ob-RL and 
DDR2, as well as extracellular matrix-remodeling proteins such as MMP-2, TIMP-2, and MT1-MMP (Xu et al., 
2005). Their phenotype is considerably heterogeneous in vivo, and is likely to reflect the influence of cell-cell 
communication, including with cancerous cells, as well as their interactions with the extracellular matrix and 
soluble factors. We used in our study the LX-2 cell line, which greatly recapitulates the in vivo phenotype of 
activated primary hepatic stellate cells (Xu et al., 2005). Its molecular phenotype and activated state was 
previously validated in our laboratory by microarray (Coulouarn et al., 2012). This cell line thus represents a 
relevant model to study the bidirectional crosstalk between paired primary and metastatic UMC lines, which are 
very rare in the field of UM (Calipel et al., 2011; Griewank et al., 2012), and activated stellate cells from the 
hepatic microenvironment. We showed that in both metastatic co-culture conditions the transcriptional 
deregulation was more substantial than in non-metastatic UMCs. Our data suggest for the first time that metastatic 
UMCs are more sensitive to the paracrine signaling of HSCs than non-metastatic UMCs. Their interactions 
generated a pro-inflammatory, pro-angiogenic and pro-fibrogenic microenvironment.  
 
There is growing evidence that inflammation plays an important role in the initiation phase of UM (Bronkhorst 
and Jager, 2012), since its genetic instability was associated with an increased number of tumor-infiltrating 
macrophages and high expression of HLA classes I and II (Bronkhorst and Jager, 2013). However, the literature is 
scarce concerning the immune microenvironment of metastatic UM (Grossniklaus et al., 2016; Krishna et al., 
2017; Qin et al., 2017). In the present study, the co-culture of activated hepatic stellate cells with a pair of UMC 
lines derived from a primary tumor and its corresponding liver metastasis increased significantly the secretion of 
pro-inflammatory and pro-fibrogenic interleukins IL6 and IL8. Interestingly, both interleukins were found at high 
concentrations in the serum of patients with colorectal cancer liver metastases (Ueda et al., 1994), and higher 
serum levels of IL6 could distinguish patients with primary liver tumors or breast cancer liver metastases from 
patients with benign liver lesions or without metastasis (Coskun et al., 2004). Moreover, high levels of IL6 were 
previously associated with poor prognosis in both uveal and cutaneous melanomas (Likhvantseva et al., 1997; 
Moretti et al., 2001), while high levels of IL8 were linked to increased metastasis in various cancers (Brat et al., 
2005; Inoue et al., 2000; Xie, 2001).  
 
Surprisingly, the proliferation of UMC lines was not significantly modified by the paracrine signaling of 
HSCs. According to clinical experience, some UM patients have metastatic lesions that remain stable during 
several weeks or months, but then proliferate exponentially and invade the liver (Mouriaux et al., 2016a). Such 
initial non-proliferation of UMCs may be due to the inhibitory effect of the microenvironment. Here we observed 
a decrease of Cyclin D1 and p21 proteins in UMC lines co-cultured with HSCs, what may seem contradictory. 
However, an inverse correlation between the p21 gene expression and evolution from normal skin melanocyte to 
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metastatic melanoma has been previously described (Jiang et al., 1995). It can be explained as a corollary of 
tumor cells having escaped terminal differentiation and growth arrest by becoming resistant to inhibitory signals 
from p21 (Mouriaux et al., 1998; Mouriaux et al., 2000). Another possibility is that UMCs exhibit a high level of 
aggressiveness that is not reflected by a high proliferation rate, but rather by their ability to persist in time in a 
somewhat hostile environment. Moreover, dynamic adhesion processes are crucial for conferring the migration 
abilities of cancer cells. For example, metastatic breast cancer cell lines expressed higher levels of integrin 
subunits than non-metastatic cells (Rizwan et al., 2015). Indeed, several integrins were upregulated in metastatic 
UMCs co-cultured with activated HSCs, while the cell adhesion to extracellular matrix only increased in non-
metastatic cells. It thus suggests that metastatic UMCs retained their adhesive phenotype, a property required to 
invade a secondary organ. In addition, several integrins act as cell surface receptors for growth factors such as 
TGFβ (a master regulator of fibrosis), ANGPTL and VEGFA (LaFoya et al., 2018); corresponding transcripts 
were indeed increased in our co-culture conditions. 
 
IL6-mediated activation of the STAT3 signaling pathway has been shown to regulate cancer cell proliferation, 
survival, invasion and metastasis (Teng et al., 2014). A growing number of clinical studies have shown the 
potential use of the IL6 receptor inhibitor TCZ for the treatment of cancer (Nishimoto et al., 2005; Sato et al., 
1993). We reported here that the TCZ was a very potent inhibitor of the inflammatory profile showed in UMCs 
when co-cultured with HSCs. A treatment with TCZ reduced the level of phosphorylated STAT3 in our co-culture 
conditions, STAT3 being a downstream effector of IL6, which is activated in UMCs exposed to the HSC 
conditioned medium. However, we did not find any modification of the proliferation of UMCs using such 
treatment. In fact, anti-IL6 or anti-IL6R monoclonal antibodies have not demonstrated a clinical efficacy in 
various types of cancer despite evidences showing the involvement of IL6 in controlling the growth of malignant 
cells and of their healthy counterparts (Rossi et al., 2015). The lack of effect of IL6 inhibitors in cancer is not due 
to an overproduction of IL6 compared to inflammatory diseases, but rather by the plasticity of tumor cells and the 
presence of various subclones using growth factors other than this interleukin (Rossi et al., 2015). Finally, it is 
possible that the IL6 was inadequately suppressed in the microenvironment given the possibility of paracrine, 
autocrine, and intracrine production by tumor cells, and compensatory effects from other growth factors, which 
counteract the simple blocking of this cytokine (Ho et al., 2015).  
 
Our findings could potentially benefit immunotherapy of UM. For example, many genes are regulated by the 
cytokine TGFβ1, which suppresses the immune response by inducing fibrosis and inflammation in aggressive 
cancers. Ongoing trials for metastatic pancreatic cancer and hepatocellular carcinoma are currently testing in 
Phase 1 or 2 the TGFβ1 inhibitor Galunisertib in combination with checkpoints inhibitors (Herbertz et al., 2015; 
https://clinicaltrials.gov, Identifiers# NCT02423343 and NCT02734160). 
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5. Conclusions 
In conclusion, our study demonstrates an increased secretion of inflammatory mediators in UMCs co-cultured 
with activated HSCs, without an effect on the proliferation of UMCs. Metastatic UMCs were more responsive to 
the paracrine signaling of HSCs than their non-metastatic counterpart, and conversely. Further investigation of the 
molecular mechanisms that may explain this discrepancy is underway (e.g. higher expression or sensitivity of the 
receptors, higher production of soluble factors). A better understanding of the interplay between HSCs and UMCs 
could be used to discover new therapeutic targets for the metastatic stage such as pro-fibrogenic interleukins. 
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Figures legends 
 
Fig. 1. Overexpressed transcripts in co-culture were linked to inflammation. A. A proportional Venn diagram 
representing the overlap of deregulated transcripts in OMM2.3/LX-2 (white) and Mel270/LX-2 (black) co-culture 
conditions. B. A proportional Venn diagram representing the overlap of deregulated transcripts in LX-2/OMM2.3 
(white) and LX-2/Mel270 (black) co-culture conditions. C. Volcano plots (left) demonstrating differentially 
expressed transcripts in UMC lines grown alone (Mel270, OMM2.3) or co-cultured with HSCs (Mel270/LX-2, 
OMM2.3/LX-2). Bar graphs (right) showing the expression of cytokines IL1β, IL6, IL6ST, IL8 and VEGFA in 
these conditions. D. Volcano plots (left) demonstrating differentially expressed transcripts in HSCs grown alone 
(LX-2), in co-culture with Mel270 (LX-2/Mel270) or co-cultured with OMM2.3 (LX-2/OMM2.3). Bar graphs 
(right) showing the expression of cytokines IL1β, IL6, IL6ST, IL8 and VEGFA in these conditions. Transcripts 
listed in volcano plots in C and D were selected on the basis of the significance for their differential expression in 
monoculture versus co-culture conditions (horizontal dotted lines; P<0.001) and the level of induction or 
repression (vertical dotted lines; fold change>2). Total RNA was extracted after 48 hours and subjected to 
microarray analysis. 
Fig. 2. Quantitative analysis of the expression of cytokine transcripts in co-cultures of UMCs and HSCs. A-
B. Mel270 and OMM2.3 cells were grown alone or co-cultured with HSCs (Mel270/LX-2; OMM2.3/LX-2). C-
D. LX-2 cells were grown alone or in co-culture with UMCs (LX-2/Mel270; LX-2/OMM2.3). Total RNA was 
harvested after 48 hours and the expression of cytokines IL1β, IL6, IL6ST, IL8 and VEGFA was analyzed by 
QPCR. *P<0.05, **P<0.01, ***P<0.001. 
Fig. 3. Quantitative analysis of the production of cytokines in co-cultures of UMCs and HSCs. A-B. Mel270 and 
OMM2.3 cells were grown alone or co-cultured with HSCs (Mel270/LX-2; OMM2.3/LX-2). C-D. LX-2 cells 
were grown alone or in co-culture with UMCs (LX-2/Mel270; LX-2/OMM2.3). Supernatants were collected after 
48 hours and the secretion of cytokines IL1β, IL6, IL6ST, IL8 and VEGFA was analyzed by ELISA. *P<0.05, 
**P<0.01, ***P<0.001. 
Fig. 4. Effect of co-culture conditions on cell adhesion of both UMCs and HSCs. A-B. Mel270 and OMM2.3 cells 
were incubated in monoculture conditioned media (Mel270; OMM2.3) or co-culture conditioned media 
(Mel270/LX-2; OMM2.3/LX-2). C-D. LX-2 cells were incubated in monoculture conditioned medium (LX-2) or 
co-culture conditioned media (LX-2/Mel270; LX-2/OMM2.3). Cells were seeded into plates coated with 
substrates (extracellular matrix proteins: FN, COL I, COL IV, LN, FBG; negative control: BSA) for 90 min at 
100,000 cells/well. Adherent cells were captured, stained and quantified colorimetrically (OD 560 nm).  
Fig. 5. Effect of co-culture conditions on cell proliferation of both UMCs and HSCs. A. Mel270, OMM2.3 and 
LX-2 cells were seeded on 96-well plates and treated with conditioned media from monocultures or co-culture 
conditions. Cell proliferation was measured 24 or 48 hours post-treatment using the MTT colorimetric assay. 
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B. Total RNA from Mel270, OMM2.3 and LX-2 cells treated with conditioned media from monocultures or co-
culture conditions was harvested after 48 hours. The expression of the cell proliferation transcript MKI67 was 
analyzed by QPCR. C. The expression of cell proliferation transcripts CCND1 and CDKN1A was analyzed by 
microarray. D. Total proteins from Mel270, OMM2.3 and LX-2 cells treated with conditioned media from 
monocultures or co-culture conditions were harvested after 48 hours and the expression of cell proliferation 
proteins Cyclin D1 and p21 was quantified by Western blotting (β-Actin, control loading). *P<0.05, **P<0.01, 
***P<0.001. 
Fig. 6. Quantitative analysis of the expression of cytokine transcripts in co-cultures of UMCs and HSCs treated 
with Tocilizumab (TCZ). A-B. Mel270 and OMM2.3 cells were grown in co-culture with HSCs (Mel270/LX-2, 
OMM2.3/LX-2) or treated with TCZ (Mel270/LX-2 TCZ, OMM2.3/LX-2 TCZ). C-D. LX-2 cells were grown in 
co-culture with UMCs (LX-2/Mel270, LX-2/OMM2.3) or treated with TCZ (LX-2/Mel270 TCZ, LX-2/OMM2.3 
TCZ). Total RNA was harvested after 48 hours and the expression of cytokines IL1β, IL6, IL6ST, IL8 and 
VEGFA was analyzed by QPCR. *P<0.05, **P<0.01, ***P<0.001. 
 
Suppl. Fig. 1. Experimental design of co-cultures of HSCs and UMCs. A-B. LX-2 cells (HSCs) were seeded onto 
cell culture inserts with 1 µm pore size (upper chamber) and were loaded into 6-well receiver plates containing 
UMC lines Mel270 (A) or OMM2.3 (B). This pore size allows the diffusion of secreted components in the 
medium but prevents cell migration toward the lower chamber. C-D. Mel270 or OMM2.3 cells were seeded onto 
cell culture inserts (upper chamber) and were loaded into 6-well receiver plates containing LX-2 cells. HSCs and 
UMCs were cultured alone or side-by-side for 48 hours, and then RNA and proteins were extracted from the cells 
and subjected to microarray analyses and Western blotting. Supernatants were collected from inserts to perform 
ELISA analyses or used later as conditioned medium (CM). 
Suppl. Fig. 2. Extracellular matrix array. Adherent cells were stained and quantified colorimetrically after 90 min 
of incubation (purple; OD 560 nm). Extracellular matrix proteins: FN, COL I, COL IV, LN, FBG; negative 
control: BSA.  
Suppl. Fig. 3. Comparison between UMC lines grown alone. A. Typical spindle morphology of UMC lines 
grown alone (Mel270, OMM2.3) or co-cultured with LX-2 cells (Mel270/LX-2, OMM2.3/LX-2) for 48 hours. 
Scale bar, 50 µm. B. A volcano plot demonstrating differentially expressed transcripts in Mel270 and OMM2.3 
cell lines grown alone. Transcripts listed in the volcano plot were selected on the basis of the significance for their 
differential expression in Mel270 cells versus OMM2.3 cells (horizontal dotted lines; P<0.01) and the level of 
induction or repression (vertical dotted lines; fold change>1.5). Total RNA was extracted after 48 hours and 
subjected to microarray analysis. C. Supernatants were collected after 48 hours from UMC lines grown alone, and 
the secretion of cytokines IL1β, IL6, IL6ST, IL8 and VEGFA was analyzed by ELISA. *P<0.05. 
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Suppl. Fig. 4. Proportional Venn diagrams representing the overlap of upregulated (A and B) or downregulated 
(C and D) transcripts in co-culture conditions. A. OMM2.3 (white) and Mel270 (black) were grown alone or co-
cultured with LX-2 cells. B. LX-2 cells were grown alone or co-cultured with OMM2.3 (white) or Mel270 (black) 
cells. C. OMM2.3 (white) and Mel270 (black) were grown alone or co-cultured with LX-2 cells. D. LX-2 cells 
were grown alone or co-cultured with OMM2.3 (white) or Mel270 (black) cells. Transcripts listed in A to D were 
selected on the basis of the significance for their differential expression in monoculture versus co-culture 
conditions. Total RNA was extracted after 48 hours and subjected to microarray analysis. 
Suppl. Fig. 5. Quantitative analysis of the expression of integrin transcripts in co-cultures of UMCs and HSCs. 
A. Heatmap of the relative expression of alpha and beta integrin subunits in LX-2 cells and UMCs grown alone or 
in co-culture. The quantification is presented as percentage of relative expression in grayscale, where the largest 
value appears in black (100%), and the smallest value in white (0%). B. LX-2 cells were grown alone or in co-
culture with UMCs (LX-2/Mel270, LX-2/OMM2.3). C. Mel270 and OMM2.3 cells were grown alone or co-
cultured with HSCs (Mel270/LX-2, OMM2.3/LX-2). Total RNA was harvested after 48 hours and the expression 
of integrins ITGA1, ITGA3, ITGA4, ITGA5, ITGA10, ITGAX, ITGB2, ITGB3, ITGB4 and ITGB8 was analyzed 
by microarray. Fold change >2.00* or <0.50**. 
Suppl. Fig. 6. Effect of TCZ on STAT3 expression/activation and proliferation of UMC lines. A. Total proteins 
from Mel270, OMM2.3, and LX-2 cells grown alone or in co-culture conditions (Mel270/LX-2, OMM2.3/LX-2, 
LX-2/Mel270, LX-2/OMM2.3) and treated with TCZ were harvested after 48 hours. The expression of phosphor-
STAT3 and total STAT3 was quantified by Western blotting (β-Actin, control loading). B-D. Cell proliferation 
was measured 48 hours post-TCZ treatment using the MTT colorimetric assays. E-H. Total RNA from Mel270, 
OMM2.3 and LX-2 cells grown alone or in co-culture conditions (Mel270/LX-2, OMM2.3/LX-2, LX-2/Mel270, 
LX-2/OMM2.3) treated with TCZ was harvested after 48 hours. The expression of the STAT3 transcript was 
analyzed by QPCR. *P<0.05, **P<0.01, ***P<0.001. 
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Highlights 
• Uveal melanoma is peculiar for its high propensity to spread to the liver 
• Stellate cells are the most reactive cells of the liver in presence of metastases 
• Metastatic cells are more sensitive to the paracrine signaling of stellate cells 
• Inflammatory mediators are key players in the homing of uveal melanoma to the liver 
 
